Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. (Annals of the rheumatic diseases, 2006)

(untitled) - Reginster, J; Adami, S; Lakatos, P; Greenwald, M; Stepan, J; Silverman, S; Christiansen, C; Rowell, L; Mairon, N; Bonvoisin, B; Drezner, M; Emkey, R; et al.